Biotech company Biogen lowered its full-year profit forecast, citing higher costs related to its purchase of drug maker Reata Pharmaceuticals as well as the launch of its Alzheimer's drug.
Share:
More In Business
FDA Bans Sale of Top Selling Vaping Product
FDA Bans Sale of Top Selling Vaping Product
Big Business This Week: Microsoft Seals the Deal, Sony's New PlayStation, Dollar General's New Old CEO
The Week's Top Stories is a guided tour through the biggest market stories of the week, from winning stocks to brutal dips to the facts and forecasts generating buzz on Wall Street.
Stretching Your Dollar: The Biggest Cost When it Comes to Wedding Planning
Breaking down the cost of weddings.
Stretching Your Dollar: What to Know About Saving for Retirement
Stretching Your Dollar: What to Know About Saving for Retirement
Healthcare Workers Reach Tentative Agreement
Unionized health care workers have struck a tentative agreement with Kaiser Permanente after the biggest health care strike in U.S. history.
Major Banks Report Better Than Expected Q3 Earnings
Major Banks Report Better Than Expected Q3 Earnings
UAW: 'Entering New Phase' In Strike
Shawn Fain, the president of the United Auto Workers, gave an update on the ongoing strike against the Detroit three automakers.
Microsoft Closes Activision Blizzard Deal for $69 Million
Microsoft closed its $69 billion acquisition of Activision Blizzard in one of the largest tech and gaming deals in history.
Stocks Jump After Strong Bank Earnings
Stocks jumped after strong earnings reports from big banks.
